The determination of causality of drug induced liver injury in patients with COVID-19 clinical syndrome

An investigation into the avoidability of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome

(2021) Mohammed Ibn-Mas’ud Danjuma et al.   Scientific Reports

Drug-Induced Liver Injury in COVID-19 Patients: A Systematic Review

(2021) Fatemeh Sodeifian et al.   Frontiers in Medicine

An investigation into the avoidability of adverse drug reactions using the LAAT and modified Hallas tools

(2020) Mohammed Ibn-Mas’ud Danjuma et al.   MEDICINE

Abnormal liver function tests in COVID‐19 patients: relevance and potential pathogenesis

(2020) Anna Bertolini et al.   HEPATOLOGY

Avoidability of drug-induced liver injury (DILI) in an elderly hospital cohort with cases assessed for causality by the updated RUCAM score

(2020) Mohammed Ibn-Mas’ud Danjuma et al.   BMC Geriatrics

Roussel Uclaf Causality Assessment Method for Drug-Induced Liver Injury: Present and Future

(2019) Gaby Danan et al.   Frontiers in Pharmacology

Hepatotoxicity Associated With Statins: Reports of Idiosyncratic Liver Injury Post-Marketing

(2018) Einar Bjornsson et al.   GASTROENTEROLOGY

Hepatobiliary and pancreatic: Comparison between Chinese herbal medicine and Western medicine-induced liver injury of 1985 patients

(2016) Yun Zhu et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Drug-Induced Liver Injury: Expanding Our Knowledge by Enlarging Population Analysis With Prospective and Scoring Causality Assessment

(2015) Rolf Teschke et al.   GASTROENTEROLOGY

Population-Representative Incidence of Drug-Induced Acute Liver Failure Based on an Analysis of an Integrated Health Care System

(2015) David S. Goldberg et al.   GASTROENTEROLOGY

RUCAM in Drug and Herb Induced Liver Injury: The Update

(2015) Gaby Danan et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Causality assessment methods in drug induced liver injury: Strengths and weaknesses

(2011) Miren García-Cortés et al.   JOURNAL OF HEPATOLOGY